WHSC1L2P

Across TCGA pan-cancer cohorts, WHSC1L2P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated WHSC1L2P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher WHSC1L2P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated WHSC1L2P expression acts as an unfavorable survival marker, although some lineages such as CHOL and LUSC show a favorable association.

KIRC, KIRP, and CHOL are the cancer types where WHSC1L2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Quartile	II,III,IV	0.392	0.633	.003	62	view →
KIRP	DFS	Quartile	All	0.342	0.810	.001	35	view →
CHOL	OS	Median	All	0.781	0.417	.004	26	view →
LUSC	OS	Median	All	0.824	0.696	<.001	20	view →
LGG	DFS	Tertile	All	0.778	0.866	.008	17	view →
LIHC	DFS	Quartile	All	0.441	0.586	.004	16	view →
KICH	DFS	Median	III,IV	0.317	0.796	.016	14	view →
COAD	OS	Quartile	All	0.925	0.757	.013	12	view →
THCA	DFS	Quartile	IV	0.523	1.000	.027	12	view →
PRAD	DFS	Quartile	All	0.892	0.771	.023	12	view →
READ	OS	Median	IV	0.520	1.000	.011	11	view →
GBM	OS	Median	All	0.216	0.308	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

WHSC1L2P–KIRC (OS)

Open the KIRC breakdown →